Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous and Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00378768
What this trial is testing

Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center 12
Post-approval studies (Phase 4)UnknownNCT00199147
What this trial is testing

Efficacy of G-CSF-Priming in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
Johann Wolfgang Goethe University Hospital 250
Testing effectiveness (Phase 2)Study completedNCT03961919
What this trial is testing

Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesTransplant-Related Hematologic Malignancy
Ciceri Fabio 15
Testing effectiveness (Phase 2)Study completedNCT05082675
What this trial is testing

Stem Cell Translpantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma
European Society for Blood and Marrow Transplantation 357
Early research (Phase 1)UnknownNCT00223067
What this trial is testing

Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes

Who this might be right for
Renal Transplantation
University Hospital Schleswig-Holstein 10
Early research (Phase 1)Looking for participantsNCT06465160
What this trial is testing

Evaluate the MNV-201 in Patients With Low Risk MDS

Who this might be right for
Myelodysplastic Syndromes
Minovia Therapeutics Ltd. 15
Not applicableLooking for participantsNCT07205523
What this trial is testing

High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)

Who this might be right for
Hematopoietic Stem Cell Transplantation (HSCT)Acute Myeloid Leukemia (AML)Leukemias, Acute Myeloid+12 more
Yigeng Cao,MD,PhD 1,000
Early research (Phase 1)Looking for participantsNCT05018793
What this trial is testing

Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI

Who this might be right for
Spinal Cord Injuries
The Foundation for Orthopaedics and Regenerative Medicine 15
Testing effectiveness (Phase 2)Study completedNCT00005606
What this trial is testing

Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Northwestern University
Not applicableLooking for participantsNCT01166009
What this trial is testing

CIBMTR Research Database

Who this might be right for
Autologous Stem Cell TransplantationAllogeneic Stem Cell TransplantationSolid Tumors+4 more
Center for International Blood and Marrow Transplant Research 99,999,999
Not applicableStudy completedNCT00558948
What this trial is testing

Musculoskeletal Outcomes After Bone Marrow Transplant

Who this might be right for
Survivors of Bone Marrow TransplantAutologous and Allogeneic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Not applicableLooking for participantsNCT07253129
What this trial is testing

Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 88
Not applicableLooking for participantsNCT04263857
What this trial is testing

Register of Blood Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Technical University of Munich 5,000
Not applicableStudy completedNCT01735526
What this trial is testing

Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide After Hematopoietic Stem-cell Transplantation

Who this might be right for
Lung Disease
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06149403
What this trial is testing

Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCT

Who this might be right for
MPS-IH (Hurler Syndrome)
Orchard Therapeutics 41
Very early researchStudy completedNCT03360708
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Giant Cell GlioblastomaRecurrent GlioblastomaRecurrent Gliosarcoma
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT02549586
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance

Who this might be right for
Complication of Transplanted Organ, Nos
Gary A Levy, O. Ont. MD. FRCP AGAF 5
Testing effectiveness (Phase 2)Looking for participantsNCT05071222
What this trial is testing

Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE)

Who this might be right for
Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
Assistance Publique - Hôpitaux de Paris 7
Testing effectiveness (Phase 2)Study completedNCT00002552
What this trial is testing

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 40
Large-scale testing (Phase 3)Study completedNCT00002514
What this trial is testing

Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 1,929
Next Page